HomeCompareSMDPY vs GBDC

SMDPY vs GBDC: Dividend Comparison 2026

SMDPY yields 16.48% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.75M in total portfolio value
10 years
SMDPY
SMDPY
● Live price
16.48%
Share price
$12.14
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$1.85
Full SMDPY calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — SMDPY vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMDPYGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMDPY + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMDPY pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMDPY
Annual income on $10K today (after 15% tax)
$1,400.91/yr
After 10yr DRIP, annual income (after tax)
$1.57/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,930,872.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMDPY + GBDC for your $10,000?

SMDPY: 50%GBDC: 50%
100% GBDC50/50100% SMDPY
Portfolio after 10yr
$10.40M
Annual income
$8,194,632.63/yr
Blended yield
78.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SMDPY
No analyst data
Altman Z
2.3
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMDPY buys
0
GBDC buys
0
No recent congressional trades found for SMDPY or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMDPYGBDC
Forward yield16.48%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%51.1%
Portfolio after 10y$22.6K$20.78M
Annual income after 10y$1.85$16,389,263.41
Total dividends collected$1.7K$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: SMDPY vs GBDC ($10,000, DRIP)

YearSMDPY PortfolioSMDPY Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,524$824.06$12,490$1,790.28$966.00GBDC
2$12,775$443.76$16,522$3,157.73$3.7KGBDC
3$13,899$229.87$23,578$5,898.68$9.7KGBDC
4$14,988$116.87$37,115$11,886.75$22.1KGBDC
5$16,096$58.89$66,136$26,423.57$50.0KGBDC
6$17,253$29.55$137,257$66,491.44$120.0KGBDC
7$18,475$14.80$341,734$194,868.54$323.3KGBDC
8$19,776$7.41$1,050,788$685,133.02$1.03MGBDC
9$21,164$3.70$4,099,314$2,974,971.01$4.08MGBDC
10$22,647$1.85$20,775,530$16,389,263.41$20.75MGBDC

SMDPY vs GBDC: Complete Analysis 2026

SMDPYStock

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Full SMDPY Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this SMDPY vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMDPY vs SCHDSMDPY vs JEPISMDPY vs OSMDPY vs KOSMDPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.